Select Page

Migraine

For information on migraine clinical trials, please contact Angela Moore (angela.moore2@mcgill.ca).

 

Current Recruiting Studies

Evaluation of Galcanezumab in the Prevention of Chronic Migraine

From clinicaltrials.gov:
The main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with chronic migraine.

More information

Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®

From clinicaltrials.gov:
This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.

More information